- Home
- SGML vs OLMA Comparison
SGML vs OLMA Comparison
Compare SGML & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGML | OLMA |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 949.3M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SGML | OLMA |
|---|---|---|
| Price | $8.47 | $6.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | $11.33 | ★ $36.50 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $95.18 | N/A |
| Revenue Next Year | $158.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.62 | $6.65 |
| 52 Week High | $24.48 | $36.26 |
Technical Indicators
Market Signals| Indicator | SGML | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 37.36 | 17.22 |
| Support Level | $7.79 | N/A |
| Resistance Level | $10.50 | $11.27 |
| Average True Range (ATR) | 0.55 | 0.41 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 27.24 | 6.38 |
Price Performance
Historical ComparisonAbout SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.